Calorimetry, Morphometry, Oxidative Stress, and Cardiac Metabolic Response to Growth Hormone Treatment in Obese and Aged Rats

Abstract

This study investigated the effects of growth hormone therapy on energy expenditure, lipid profile, oxidative stress and cardiac energy metabolism in aging and obesity conditions. Life expectancy is increasing in world population and with it, the incidence of public health problems such as obesity and cardiac alterations. Because growth hormone (GH) concentration is referred to be decreased in aging conditions, a question must be addressed: what is the effect of GH on aging related adverse changes? To investigate the effects of GH on cardiac energy metabolism and its association with calorimetric parameters, lipid profile and oxidative stress in aged and obese rats, initially 32 male Wistar rats were divided into 2 groups (n=16), C: given standard-chow and water; H: given hypercaloric-chow and receiving 30% sucrose in its drinking water. After 45 days, both C and H groups were divided into 2 subgroups (n=8), C+PL: standard-chow, water, and receiving saline subcutaneously; C+GH: standard-chow, water, and receiving 2 mg/kg/day rhGH subcutaneously; H+PL: hypercaloric-chow, 30% sucrose, receiving saline subcutaneously; H+GH: hypercaloric-chow, 30% sucrose, receiving rhGH subcutaneously. After 30 days, C+GH and H+PL rats had higher body mass index, Lee-index, body fat content, percent-adiposity, serum triacylglycerol, cardiac lipid-hydroperoxide, and triacylglycerol than C+PL. Energy-expenditure (RMR)/body weight, oxygen consumption and fat-oxidation were higher in H+GH than in H+PL. LDL-cholesterol was highest in H+GH rats, whereas cardiac pyruvate-dehydrogenase and phosphofrutokinase were higher in H+GH and H+PL rats than in C+PL. In conclusion, the present study brought new insights on aging and obesity, demonstrating for the first time that GH therapy was harmful in aged and obesity conditions, impairing calorimetric parameters and lipid profile. GH was disadvantageous in control old rats, having undesirable effects on triacylglycerol accumulation and cardiac oxidative stress.

Key words

growth hormone - obesity - aging - cardiac energy metabolism

References

• 1 Kireev RA, Tresguerres ACF, Castillo C, Salazar V, Ariznavarreta C, Vara E, Tresguerres JAF. Effect of exogenous administration of melatonin and growth hormone on pro-oxidant functions of the liver in aging male rats.  J Pineal Res. 2007;  42 64-70
• 2 Everitt AV, Cavanagh LM. The ageing process in the hypophysectomized rat.  Gerontologia. 1965;  11 198-207
• 3 Brown-Borg HM. Hormonal regulation of longevity in mammals.  Ageing Res Rev. 2007;  6 28-45
• 4 Copeland KC, Colleti BR, Devlin JT, McAuliffe TL. The relationship between insulin-like growth factor-I, adiposity and aging.  Metabolism. 1990;  39 584-587
• 5 Hajima SV, Van Dam PS, Vries WR, Maitimu-Smeele I, Dieguez C, Casanueva FF, Koppeschaar HP. The GHRH/GHRP-6 test for diagnosis of GH deficiency in elderly or severely obese men.  Eur J Endocrinol. 2005;  152 575-580
• 6 Shadid S, Jensen MD. Effects of growth hormone administration in human obesity.  Obes Res. 2003;  11 170-175
• 7 Despres JP, Lemieux I, Prud’homme D. Treatment of obesity: need to focus on high risk abdominally obese patients.  Br Med J. 2001;  322 716-720
• 8 Cuttica CM, Castoldi L, Gorrini GP, Peluffo F, Delitala G, Filippa P, Fanciulli G, Giusti M. Effects of six-month administration of rhGH to healthy elderly subjects.  Aging. 1997;  9 193-197
• 9 Angelopoulos TJ, Seip RL, Cole TG. Effect of short-term recombinant hGH administration on plasma lipoprotein in elderly adults.  Gerontology. 1998;  44 228-231
• 10 Hill JO. Understanding and addressing the epidemic of obesity: an energy balance perspective.  Endocr Rev. 2006;  27 750-761
• 11 Castillo C, Cruzado M, Ariznavarreta C, Gil-Loyzaga P, Lahera V, Cachofeiro V, Tresguerres JA. Effect of recombinant human growth hormone on body composition and vascular function and structure in old male Wistar rats.  Biogerontology. 2005;  6 303-312
• 12 Rosén T, Bengtsson BA. Premature mortality due to cardiovascular disease in hypopituitarism.  Lancet. 1990;  336 285-288
• 13 Novelli ELB, Souza GA, Ebaid GMX, Rocha KKHR, Seiva FRF, Mani F, Campos KE, Sforcin JM. Energy expenditure and oxygen consumption as novel biomarkers of obesity-induced cardiac disease in rats.  Obesity. 2010;  18 1754-1761
• 14 Souza GA, Ebaid GX, Seiva FRF, Rocha KHR, Galhardi CM, Mani F, Novelli ELB. N-acetylcysteine in Allium plant compound improves high sucrose diet-induced obesity and related effects.  Evid Based Complement Alternat Med. 2008;  11 1-7
• 15 Seiva FRF, Ebaid GMX, Castro AVB, Okoshi K, Nascimento A, Rocha KKH, Padovani CR, Cicogna AC, Novelli ELB. Growth Hormone and heart failure: oxidative stress and energetic metabolism in rats.  Growth Horm IGF-I Res. 2008;  18 275-283
• 16 Pérez-Romero A, Amores A, Salamé F, Ariznavarreta C, Tresguerrez JÁ. Efectos de la administración de rhGH en ratas macho viejas.  Endocrinol Nutr. 1999;  46 31
• 17 Seiva FRF, Berbert CMS, Souza GA, Rocha KKH, Ebaid GMX, Burneiko RCM, Novelli ELB. Energy expenditure, lipid profile, oxidative stress and cardiac energy metabolism after growth hormone treatment in obese young rats.  Horm Metab Res. 2010;  42 486-501
• 18 Novelli ELB, Santos P, Assalin H, Souza G, Rocha K, Ebaid G, Seiva F, Mani F, Fernandes A. N-acetylcysteine in high sucrose induced obesity: energy expenditure, metabolic shifting for cardiac health.  Pharmacol Res. 2009;  59 74-79
• 19 Novelli ELB, Diniz YS, Galhardi C, Ebaid G, Rodrigues H, Mani F. Anthropometrical parameters and markers of obesity in rats.  Lab Anim. 2007;  41 111-119
• 20 Nascimento AF, Sugizaki MM, Leopoldo AS, Lima-Leopoldo AP, Nogueira CR, Novelli ELB, Padovani CR, Cicogna AC. Misclassification probability as obese or lean in hypercaloric and normocaloric diet.  Biol Res. 2008;  41 253-259
• 21 Labayen I, Forga L, Martinez JA. Nutrient oxidation and metabolic rate as affected by meals containing different proportions of carbohydrate and fat, in healthy young women.  Eur J Nutr. 1999;  38 158-166
• 22 Diniz YS, Burneiko RM, Seiva FRF, Almeida FQA, Galhardi CM, Novelli Filho JLVB, Mani F, Novelli ELB. Diet compounds, glycemic index and obesity-related cardiac effects.  Int J Cardiol. 2008;  124 92-99
• 23 Castelli WP, Abbot RD, Mcnamara PM. Summary estimates of cholesterol used to predict coronary heart disease.  Circ. 1983;  67 730-734
• 24 Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin-phenol reagent.  J Biol Chem. 1951;  193 265-275
• 25 Jiang ZY, Woollard A, Wolff S. Lipid hydroperoxide measurement by oxidation of Fe 3+ in the presence of xylenol orange.  Lipids. 1991;  26 853-856
• 26 Bass A, Brdicka PE, Eyer P, Hofer S, Pette D. Metabolic differentiation of distinct muscle types at the level of enzymatic organization.  Eur J Biochem. 1969;  10 198-206
• 27 Iossa S, Lionetti L, Mollica MP, Barletta A, Liverini G. Energy intake and utilization vary during development in rats.  J Nutr. 1999;  129 1593-1596
• 28 Micmacher E, Assumpção RP, Redorat RG, Spina LD, Cruz IC, Silva CA, Vaisman M, Conceição FL. Growth hormone secretion in response to glucagon stimulation test in healthy middle-aged men.  Arq Bras Endocrinol Metabol. 2009;  53 853-858
• 29 Owen CG, Whincup PH, Orfei L, Chou QA, Rudnicka AR, Wathern AK, kaye SJ, Eriksson JG, Osmond C, Cook DG. Is body mass index before middle age related to coronary heart disease risk in later life? Evidence from observational studies.  Int J Obes. 2009;  7 1-12
• 30 Schmidt W, Poll-Jordan G, Loffler G. Adipose conversion of 3T3-L1 cells in a serum-free culture system depends on epidermal growth factor, insulin-like growth factor I, corticosterone, and cyclic AMP.  J Biol Chem. 1990;  265 15489-15495
• 31 Chen NX, Hausman GJ, Wright JT. Influence of thyroxine in vivo on preadipocyte development and insulin-like growth factor-I and IGF binding protein secretion in fetal stromalvascular cell cultures.  Obes Res. 1996;  4 357-366
• 32 Bieri JG, Stoenband GS, Briggs GM, Phillips RW, Woodand JC, Knpha JJ. American Institute of Nutrition. Report of the American Institute of nutrition Ad Hoc Committee on Standards for nutritional studies.  J Nutr. 1977;  107 1340-1348
• 33 Diniz YS, Santos PP, Assalin HB, Souza GA, Rocha KK, Ebaid GM, Seiva FR, Amauchi JF, Novelli Filho JL, Novelli EL. Conjugated Linoleic acid and cardiac health: oxidative stress and energetic metabolism in standard and sucrose-rich diets.  Eur J Pharmacol. 2008;  579 318-325
• 34 Bramnert M, Segerlantz M, Laurila E, Daugaard JR, Manhem P, Groop L. Growth hormone replacement therapy induces insulin resistance by activating the glucose-fatty acid cycle.  J Clin Endocrinol Metab. 2003;  88 1455-1463
• 35 Angelin B, Rudling M. Growth hormone and hepatic lipoprotein metabolism.  Curr Opin Lipidol. 1994;  5 160-165
• 36 Elam MB, Wilcox HG, Solomon SS, Heimberg M. In vivo growth hormone treatment stimulates secretion of very low density lipoprotein by the isolated perfused rat liver.  Endocrinology. 1992;  131 2717-2722
• 37 Sjoberg A, Oscarsson J, Eden S, Olofsson SO. Continuous but not intermittent administration of growth hormone to hypophysectomized rats increases apolipoprotein-E secretion from cultured hepatocytes.  Endocrinology. 1994;  134 790-798
• 38 Rudling M, Olivecrona H, Eggertsen G, Angelin B. Regulation of rat liver low density lipoprotein receptors: in vivo stimulation by growth hormone is not mediated by insulin-like growth factor I.  J Clin Invest. 1996;  97 292-299
• 39 Rollo CD, Carlson J, Sawada M. Accelerated aging of giant transgenic mice is associated with elevated free radical process.  Can J Zool. 1996;  74 606-620
• 40 Bartke A, Brown-Borg H. Life extension in the dwarf mouse.  Curr Top Dev Biol. 2004;  63 189-225
• 41 Lopaschuk GD, Folmes CDL, Stanley WC. Cardiac energy metabolism in obesity.  Circ Res. 2007;  101 335-347

Correspondence